List of participating centers, investigators and staff: Cincinnati Children's Hospital Medical Center, Cincinnati, OH: Jens Goebel; Cleveland Clinic, Cleveland, OH: Robert Fairchild, Richard Fatica, Stuart Flechner, David Goldfarb, Karen Keslar, Venkatesh Krishnamurthi, Saul Nurko, Emilio Poggio and Brian Stephany; Cornell University School of Medicine, New York, NY: M. Suthanthiran; Emory University Medical Center, Atlanta, GA: Robert Bray, Howie Gebel and Kenneth A. Newell; Egleston Children's Hospital of Emory University, Atlanta, GA: Barry L. Warshaw; Icahn School of Medicine at Mount Sinai, New York, NY: Enver Akalin, Scott Ames, Jonathan Bromberg, Graciela DeBoccardo, Rajani Dinavahi, Peter S. Heeger, Susan Lerner, Marvin Lin, Barbara Murphy, Vinay Nair, Denise Peace, Bernd Schroppel and Vinita Seghal; Transplantation Branch, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD: Nancy D. Bridges and Yvonne Morrison; Rho, Chapel Hill, NC: David Ikle, Alexander Lockhardt, Katie Poole and Michael Riggs; University Hospitals Case Medical Center, Cleveland, OH: Mark Aeder, Joshua Augustine, Donald Hricik, Aparna Padiyar and James Schulak; University of Utah School of Medicine, Salt Lake City, UT: Fuad Shihab; University of Manitoba, Winnipeg, Manitoba, Canada: Patricia Birk, Ian Gibson, Peter Nickerson and David Rush; Yale University School of Medicine, New Haven, CT: Richard Formica and Danielle Jacques.
Multicenter Validation of Urinary CXCL9 as a Risk-Stratifying Biomarker for Kidney Transplant Injury
Article first published online: 22 AUG 2013
© Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons
American Journal of Transplantation
Volume 13, Issue 10, pages 2634–2644, October 2013
How to Cite
Hricik, D. E., Nickerson, P., Formica, R. N., Poggio, E. D., Rush, D., Newell, K. A., Goebel, J., Gibson, I. W., Fairchild, R. L., Riggs, M., Spain, K., Ikle, D., Bridges, N. D., Heeger, P. S. and for the CTOT-01 consortium (2013), Multicenter Validation of Urinary CXCL9 as a Risk-Stratifying Biomarker for Kidney Transplant Injury. American Journal of Transplantation, 13: 2634–2644. doi: 10.1111/ajt.12426
- Issue published online: 24 SEP 2013
- Article first published online: 22 AUG 2013
- Manuscript Accepted: 11 MAY 2013
- Manuscript Revised: 3 MAY 2013
- Manuscript Received: 11 MAR 2013
- National Institutes of Health. Grant Number: AI63594-06
- 26Clinical prediction models. A practical approach to development, validation, and updating. New York: Springer, 2009.
- 29An introduction to the bootstrap. Monographs on statistics and applied probability. New York: Chapman and Hall/CRC Press, LLC, 1993.,